Two Neil Woodford dividend stocks you can buy for under a fiver

Edward Sheldon looks at two dividend stocks that can be bought for less than the price of a pint.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cruise Ship

Image: Public domain

Neil Woodford is the UK’s most prominent fund manager. While his performance over the last year has been underwhelming, his long-term track record is excellent. Today, I’m looking at two Woodford-owned dividend stocks that can be bought for less than £5.

Saga

At the end of September, Woodford’s Income Focus fund held a 1.34% weighting in Saga (LSE: SAGA). The £2.1bn market cap company is a leading provider of insurance, travel, personal finance and healthcare products and services to over 50s.

There’s several things I like about it. First, the UK’s ageing population should provide significant tailwinds to the company’s growth in coming years. According to ONS population projections, the number of people aged 50 and over in the UK is set to grow from 23m in 2013 to 29m in 2033, meaning this demographic will represent 40% of the population. As a key provider of services to the older generation, Saga looks well placed to capitalise on this trend.

Second, the group appears to have momentum at present, yet remains attractively valued. In its most recent half-year results, underlying profit before tax rose 5.5%. City analysts expect earnings of 14.2p this year, which at the current share price of 186p, places the stock on a forward P/E of a reasonable 13.1.

Saga also offers considerable dividend appeal. The group paid a maiden dividend of 4.1p per share in 2015, however, over the last two years has increased the payout to 7.2p and 8.5p. Analysts expect 9.2p this year, which equates to a high yield of 4.9% at the current share price.

Combining the long-term story with the attractive valuation and high yield, Saga looks to have considerable investment appeal, in my opinion.

G4S

Another Woodford holding that can be picked up cheaply is G4S (LSE: GFS). The stock made up 1.02% of Woodford’s flagship Equity Income fund at the end of September. The £4bn market cap company provides security solutions to a broad range of clients across six continents.

Like Saga, G4S appears to have a long-term theme at play. With geopolitical risk increasing at an alarming rate, demand for security solutions is likely to remain strong.

The shares have not enjoyed a great few months. Indeed, back in July, they were changing hands for 340p. However, since I covered the group’s half-year results in August, they have pulled back considerably, and now can be bought for just 256p. I’m wondering if that’s an opportunity for long-term investors?

The group stated earlier this month that trading for the first nine months of the year was in line with expectations, with organic revenue growth of 4.4%. It expects “good profit growth” for the full year. With analysts expecting 2017 earnings and dividends of 18.1p and 9.7p respectively, the recent share price weakness has lowered the company’s forward P/E to just 14.1 and boosted the yield to 3.8%. Those metrics looks attractive to me.

Edward Sheldon has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »